Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$620,000 |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$381M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$30,000 |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| FRATES JAMES M | Mar 31, 2025 | Sell | 10,896 | $3.4697 | $38,000 |
| Bedrosian Camille L | Mar 31, 2025 | Sell | 12,425 | $3.4674 | $43,000 |
| Cohen Joshua B | Mar 31, 2025 | Sell | 21,490 | $3.4659 | $74,000 |
| Klee Justin B. | Mar 31, 2025 | Sell | 21,490 | $3.4646 | $74,000 |
| Mazzariello Gina | Mar 31, 2025 | Sell | 9,192 | $3.4763 | $32,000 |
| Zeiher Bernhardt G | Mar 20, 2025 | Buy | 10,000 | $3.7005 | $37,000 |
| Klee Justin B. | Mar 3, 2025 | Sell | 4,595 | $3.152 | $14,000 |
| Cohen Joshua B | Mar 3, 2025 | Sell | 4,595 | $3.1663 | $15,000 |
| Mazzariello Gina | Mar 3, 2025 | Sell | 1,611 | $3.1175 | $5,000 |
| Mazzariello Gina | Feb 24, 2025 | Sell | 4,169 | $3.153 | $13,000 |
| Cohen Joshua B | Feb 3, 2025 | Sell | 11,851 | $3.4687 | $41,000 |
| Klee Justin B. | Feb 3, 2025 | Sell | 11,855 | $3.4672 | $41,000 |
| Mazzariello Gina | Feb 3, 2025 | Sell | 3,678 | $3.4908 | $13,000 |
| Klee Justin B. | Jan 6, 2025 | Sell | 7,471 | $4.0425 | $30,000 |
| Cohen Joshua B | Jan 6, 2025 | Sell | 7,471 | $4.0466 | $30,000 |
| Bedrosian Camille L | Dec 2, 2024 | Sell | 5,421 | $5.5354 | $30,000 |
| Klee Justin B. | Sep 30, 2024 | Sell | 18,589 | $3.197 | $59,000 |
| Cohen Joshua B | Sep 30, 2024 | Sell | 18,589 | $3.1962 | $59,000 |
| Bedrosian Camille L | Sep 30, 2024 | Sell | 11,442 | $3.1952 | $37,000 |
| Mazzariello Gina | Sep 30, 2024 | Sell | 8,709 | $3.1967 | $28,000 |
| FRATES JAMES M | Sep 12, 2024 | Buy | 40,000 | $2.5342 | $100,000 |
| Firestone Karen | Sep 5, 2024 | Buy | 50,000 | $2.1318 | $110,000 |
| MILNE GEORGE M JR | Sep 3, 2024 | Buy | 100,000 | $2.198 | $220,000 |
| Mazzariello Gina | May 15, 2024 | Sell | 10,455 | $1.8799 | $20,000 |
| Quimi Daphne | May 15, 2024 | Buy | 2,250 | $1.8899 | $4,300 |
| Quimi Daphne | May 14, 2024 | Buy | 2,750 | $1.885 | $5,200 |
| Cohen Joshua B | Mar 5, 2024 | Sell | 4,135 | $18.7279 | $77,000 |
| Klee Justin B. | Mar 5, 2024 | Sell | 4,135 | $18.7279 | $77,000 |
| Mazzariello Gina | Mar 5, 2024 | Sell | 1,540 | $18.7279 | $29,000 |
| FRATES JAMES M | Mar 5, 2024 | Sell | 1,792 | $18.7279 | $34,000 |
| Mazzariello Gina | Feb 23, 2024 | Sell | 2,838 | $18.7564 | $53,000 |
| Klee Justin B. | Jan 9, 2024 | Sell | 5,841 | $16.3281 | $95,000 |
| FRATES JAMES M | Jan 9, 2024 | Sell | 2,716 | $16.3281 | $44,000 |
| Cohen Joshua B | Jan 9, 2024 | Sell | 5,841 | $16.3281 | $95,000 |
| Yeramian Patrick D | Jan 9, 2024 | Sell | 2,812 | $16.3281 | $46,000 |
| Firestone Karen | Dec 15, 2023 | Buy | 4,000 | $14.97 | $60,000 |
| Mazzariello Gina | Aug 15, 2023 | Sell | 6,164 | $20.8771 | $130,000 |
| FRATES JAMES M | May 16, 2023 | Sell | 32,000 | $26.9266 | $860,000 |
| FRATES JAMES M | May 16, 2023 | Sell | 500 | $27.6 | $14,000 |
| Yeramian Patrick D | May 15, 2023 | Sell | 11,965 | $29.0312 | $350,000 |
What's the latest insider transaction for Amylyx Pharmaceuticals?
The most recent insider transaction for Amylyx Pharmaceuticals was conducted by FRATES JAMES M, who sold 10,896 shares on March 31, 2025 at a price of $3.47 per share.
Which insider bought the most AMLX stock over the last two years?
MILNE GEORGE M JR has bought the most AMLX stock in the last 2 years, with a total value of $220,000.
Which insider has sold the most AMLX stock over the last two years?
FRATES JAMES M has sold the most AMLX stock in the last 2 years, with a total value of $990,000.
What is the total value of insider transactions for Amylyx Pharmaceuticals (AMLX) in the last 2 years?
The total value of insider transactions for Amylyx Pharmaceuticals in the last 2 years is negative, amounting to -$2.1M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Amylyx Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Amylyx Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
